Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.nejm.org › doi › fullTwice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in...

   www.nejm.org › doi › full

   24 Ιουλ 2024 · A twice-yearly PrEP choice could overcome challenges with respect to adherence and persistence and result in substantial protection against HIV infection for women worldwide.

2. www.hiv.gov › blog › fda-approves-new-hiv-drug-for-adults-with-limited-treatmentFDA Approves New HIV Drug for Adults with Limited Treatment...

   www.hiv.gov › blog › fda-approves-new-hiv-drug-for-adults-with-limited-treatment

   • Αποθηκευμένο αντίγραφο

   4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.

3. edition.cnn.com › 2024/07/24 › healthTwice-yearly shot proves successful at preventing HIV infection...

   edition.cnn.com › 2024/07/24 › health

   • Αποθηκευμένο αντίγραφο

   24 Ιουλ 2024 · The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrating 100% efficacy in Phase 3 trial data released by drugmaker Gilead and...

4. theconversation.com › hiv-prevention-why-a-new-injectable-drug-could-be-such-aHIV prevention: why a new injectable drug could be such a...

   theconversation.com › hiv-prevention-why-a-new-injectable-drug-could-be-such-a

   • Αποθηκευμένο αντίγραφο

   3 Οκτ 2024 · A new drug to prevent HIV infection is showing hugely promising results in clinical trials when injected every six months.

5. www.medscape.com › viewarticle › 986049FDA Approves First-in-Class Drug for HIV - Medscape

   www.medscape.com › viewarticle › 986049

   22 Δεκ 2022 · The US Food and Drug Administration (FDA) has approved the medication lenacapavir (Sunlenca) for adults living with multi-drug resistant HIV-1 infection. After the initial doses are completed...

6. www.nature.com › articles › d41586/022/02123-xLong-lasting HIV prevention drug could be game changer - Nature

   www.nature.com › articles › d41586/022/02123-x

   • Αποθηκευμένο αντίγραφο

   5 Αυγ 2022 · Cabotegravir is the latest WHO-recommended drug that protects against HIV infection. In January 2021, the agency approved the use of a vaginal ring coated with the anti-HIV drug dapivirine. And...

7. www.npr.org › 2021/12/23 › 1067172062The FDA has approved a new drug in the fight against AIDS

   www.npr.org › 2021/12/23 › 1067172062

   23 Δεκ 2021 · The Food and Drug Administration has approved the first injectable medication for HIV prevention. Health advocates say it could be a game changer in protecting people against AIDS